Marcial Laura Haak, Blumenfeld Barry, Harle Christopher, Jing Xia, Keller Michelle S, Lee Victor, Lin Zhen, Dover Anna, Midboe Amanda M, Al-Showk Shafa, Bradley Victoria, Breen James, Fadden Michael, Lomotan Edwin, Marco-Ruiz Luis, Mohamed Reem, O'Connor Patrick, Rosendale Douglas, Solomon Harry, Kawamoto Kensaku
RTI International, Rockville, MD.
RTI International, Waltham, MA.
AMIA Annu Symp Proc. 2020 Mar 4;2019:637-646. eCollection 2019.
With the advent of interoperability standards such as FHIR, SMART, CDS Hooks, and CQL, interoperable clinical decision support (CDS) holds great promise for improving healthcare. In 2018, the Agency for Healthcare Research and Quality (AHRQ)-sponsored Patient-Centered CDS Learning Network (PCCDS LN) chartered a Technical Framework Working Group (TechFWG) to identify barriers, facilitators, and potential solutions for interoperable CDS, with a specific focus on addressing the opioid epidemic. Through an open, multi-stakeholder process that engaged 54 representatives from healthcare, industry, and academia, the TechFWG identified barriers in 6 categories: regulatory environment, data integration, scalability, business case, effective and useful CDS, and care planning and coordination. Facilitators and key recommendations were also identified for overcoming these barriers. The key insights were also extrapolated to CDS-facilitated care improvement outside of the specific opioid use case. If applied broadly, the recommendations should help advance the availability and impact of interoperable CDS delivered at scale.
随着FHIR、SMART、CDS Hooks和CQL等互操作性标准的出现,可互操作的临床决策支持(CDS)在改善医疗保健方面具有巨大潜力。2018年,医疗保健研究与质量局(AHRQ)资助的以患者为中心的CDS学习网络(PCCDS LN)成立了一个技术框架工作组(TechFWG),以确定可互操作CDS的障碍、促进因素和潜在解决方案,特别关注应对阿片类药物流行问题。通过一个开放的、多利益相关方参与的过程,该过程吸引了来自医疗保健、行业和学术界的54名代表,TechFWG确定了6类障碍:监管环境、数据集成、可扩展性、商业案例、有效且有用的CDS以及护理计划与协调。还确定了克服这些障碍的促进因素和关键建议。关键见解也被外推到特定阿片类药物用例之外的由CDS促进的护理改善。如果广泛应用,这些建议应有助于推动大规模提供可互操作CDS的可用性和影响力。